Lack of c-kit mutation in familial urticaria pigmentosa

British Journal of Dermatology

Volumn 140, Issue 5, 1999, Pages 849-852

  Rosbotham, Jane L ^a,c   Malik, N M ^b   Syrris, P ^b   Jeffery, S ^b   Bedlow, A ^a   Gharraie, S ^c   Murday, V A ^b   Holden, C A ^a   Carter, N D ^b  

^a ST HELIER HOSPITAL   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^c ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

C kit mutation; Familial urticaria pigmentosa; Genetic heterogeneity

Indexed keywords

MICROSATELLITE DNA;

ARTICLE; CASE REPORT; CHILD; FAMILIAL DISEASE; FEMALE; GENE MUTATION; GENETIC HETEROGENEITY; GENETIC LINKAGE; GENETIC MARKER; HUMAN; MALE; ONCOGENE C KIT; PRIORITY JOURNAL; PROTO ONCOGENE; URTICARIA PIGMENTOSA;

CHILD, PRESCHOOL; CHROMOSOME MAPPING; DNA MUTATIONAL ANALYSIS; EXONS; FEMALE; HAPLOTYPES; HETEROZYGOTE; HUMANS; MALE; PEDIGREE; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROTO-ONCOGENE PROTEINS C-KIT; URTICARIA PIGMENTOSA;

EID: 0032966221     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.1999.02814.x     Document Type: Article

References (26)

1. Greaves MW. Mastocytoses. In: Textbook of Dermatology (Champion RH, Burton JL. Ebling FJG. eds), 5th edn. Oxford: Blackwell Scientific Publications, 1992: 2065-72.
2. Burrai I, Petti R, Cavalieri S. Mastocytosis. A case of urticarial pigmentosa with systemic malignant evolution. Rec Prog Med 1993; 84: 522-5.
3. Cooper AJ, Winklemann RK, Wiltsie JC. Haematological malignancies occurring in patients with urticaria pigmentosa. J Am Acad Dermatol 1982; 7: 215-20.
4. Bazex A, Dupre A, Christol B, Andrieu H. Les mastocytoses familiales. Prēsentation de deux observations. Revue general. Intérèt nosologique. Ann Dermatol Syphilol 1971; 98: 241-60.
5. Fowler JE, Parsley WM, Cotter PG. Familial urticaria pigmentosa. Arch Dermatol 1986; 122: 80-1.
6. Rockoff AS. Urticaria pigmentosa in identical twins. Arch Dermatol 1978; 114: 1227-8.
7. Boyano T., Carrascosa T., Porta N et al. Urticaria pigmentosa in monozygotic twins. Arch Dermatol 1990; 126: 1375-6.
8. Spritz RA. Molecular basis of human piebaldism. J Invest Dermatol 1994; 103: S137-40.
9. Riva P, Milani N, Gandolfi P, Larizza L. A 12 bp deletion (7818dc112) in the c-kit protooncogene in a large Italian kindred with piebaldism. Hum Mutat 1995; 6: 343-5.
10. Ashman LK, Cambareri AC. To LB et al. Expression YB5.B8 antigen (c-kit proto-oncogene product) in normal human bone marrow. Blood 1991; 78: 30-7.
11. Funasaka Y, Boulton T, Cobb M et al. C-kit kinase induces a cascade of protein tyrosine phosphorylation in normal human skin melanocytes in response to mast cell growth factor and stimulates mitogen-activated protein kinase but is down-regulated in melanomas. Mol Cell Biol 1992; 3: 197-209.
12. Morrison-Graham K, Takahashi Y. Steel factor and c-kit receptor: from mutants to a growth factor system. Bioessays 1993; 15: 77-83.
13. Kirshenbaum AS, Goff JP, Kessler SW et al. Effect of IL-3 and stem cell factor on the appearance of human basophils and mast cells from CD34+ pluripotent progenitor cells. J Immunol 1992; 148: 772-7.
14. Vandenbark GR, de Castro CM, Taylor H et al. Cloning and structural analysis of the human c-kit gene. Oncogene 1992; 7: 1259-66.
15. Anderson DM, Williams DE, Tushinski R et al. Alternate splicing of mRNAs encoding human mast cell growth factor and locałisation of the gene to chromosome 12q22-q24. Cell Growth Differentiation 1991; 2: 373-8.
16. Nagata H, Worobea AS, Chad KO et al. Identification of a point mutation in the catalytic domain of the proto-oncogene c-kit in peripheral blood mononuclear cells of a patient who has mastocytosis with an associated hematological disorder. Proc Natl Acad Sci USA 1995; 92: 10560-4.
17. Longley BJ. Tyrrel L, Lu S-Z et al. Somatic c-kit activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm. Nature Genet 1996; 12: 312-14.
18. Nagata H, Okada T, Worobec AS et al. C-kit mutation in a population of patients with mastocytosis. Int Arch Allergy Immunol 1997; 113: 184-6.
19. Missouris CG, Barley J, Jeffery S et al. Genetic risk for renal artery stenosis: association with deletion polymorphism in angiotensin 1-converting enzyme gene. Kidney Int 1996; 19: 534-7.
20. Dib C, Faure S, Fizames C et al. A comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature 1996; 380: 152-4.
21. Spritz RA, Giebel LB, Holmes SA. Dominant negative and loss of function mutations of the c-kit (mast/stem cell growth factor receptor) proto-oncogene in human piebaldism. Am J Hum Genet 1992; 50: 261-9.
22. Clark DP, Buescher L, Harvey A. Familial urticaria pigmentosa. Arch Int Med 1990; 150: 1742-4.
23. Nettleship E. Rare forms of urticaria: I. Chronic urticaria leaving brown stains: nearly two years duration. Br Med J 1869; 2: 323-4.
24. Rollier MR. Mastocytose multinodulaire bulleuse. Bull Soc Fr Dermatol Syphilol 1958; 65: 607.
25. Havard CWH, Scott RB. Urticaria pigmentosa with visceral and skeletal lesions. Q J Med 1959; 28: 459-70.
26. Lishner M, Confino-Cohen R, Mekori YA et al. Trisomies 9 and 8 detected by fluorescence in situ hybridisation in patients with systemic mastocytosis. J Allergy Clin Immunol 1996; 98: 199-204.